US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

0.9965

+0.04574.81%

Post-market: 0.9588-0.0377-3.78%19:57 EDT

Volume:5.43M

Turnover:5.19M

Market Cap:293.97M

PE:-2.74

High:1.03

Open:0.9450

Low:0.8664

Close:0.9508

52wk High:3.07

52wk Low:0.5031

Shares:295.00M

Float Shares:208.00M

Volume Ratio:0.99

T/O Rate:2.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3641

EPS(LYR):-0.3048

ROE:-95.89%

ROA:-45.67%

PB:1.62

PE(LYR):-3.27

Loading ...

Overview Company News Filings

Invivyd expands Phase 3 VYD2311 COVID prevention trial, shifts results to Q3 2026

Invivyd Announces Revolution Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate Vms063 for Treatment and Prevention of Measles

THOMSON REUTERS

Invivyd announces annual shareholder meeting via webcast

Invivyd grants inducement stock options for 1.1 million shares to new hires

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Invivyd CSO presents monoclonal antibody development at World Vaccine Congress Washington

Invivyd Announces Presentation at the World Vaccine Congress Washington

THOMSON REUTERS

Cantor Fitzgerald Remains a Buy on Invivyd (IVVD)

Invivyd reports cash, cash equivalents of $226.7M as of December 31

Invivyd appoints Michael Mina as CMO

Invivyd FY revenue rises; operating expenses cut sharply

BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39

Invivyd Q4 net product revenue rises 31% to USD 17.2 million in Q4 2025 earnings

Invivyd Names Michael Mina Chief Medical Officer

Invivyd FY Net Income USD -52.489 Million VS. Ibes Estimate USD -57.8 Million

THOMSON REUTERS

Press Release: Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

Invivyd Inc expected to post a loss of 8 cents a share - Earnings Preview

Invivyd Grants 192,000 Inducement Stock Options to New Hires

Invivyd Price Target Maintained With a $10.00/Share by BTIG

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IVVD/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVVD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":0.9965,"timestamp":1787342400000,"preClose":0.9508,"halted":0,"volume":5426368,"hourTrading":{"tag":"盘后","latestPrice":0.9588,"preClose":0.9965,"latestTime":"19:57 EDT","volume":27545,"amount":27184.164052,"timestamp":1787356649072,"change":-0.0377,"changeRate":-0.037832,"amplitude":0.037832},"delay":0,"changeRate":0.048064787547328645,"floatShares":208000000,"shares":295000000,"eps":-0.36413848,"marketStatus":"Market Closed","change":0.0457,"latestTime":"08-21 16:00:00 EDT","open":0.945,"high":1.03,"low":0.8664,"amount":5193198.052313601,"amplitude":0.172066,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.36413848,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":0.9508,"preHourTrading":{"tag":"盘前","latestPrice":0.95,"preClose":0.9508,"latestTime":"09:24 EDT","volume":72096,"amount":68034.89504352001,"timestamp":1787318665843,"change":-0.0008,"changeRate":-0.000841,"amplitude":0.038704},"postHourTrading":{"tag":"盘后","latestPrice":0.9588,"preClose":0.9965,"latestTime":"19:57 EDT","volume":27545,"amount":27184.164052,"timestamp":1787356649072,"change":-0.0377,"changeRate":-0.037832,"amplitude":0.037832},"volumeRatio":0.9918682192009556,"impliedVol":1.1227,"impliedVolPercentile":0.4661},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","floatShares":208000000,"roa":"-45.67%","roe":"-95.89%","lyrEps":-0.304791,"volumeRatio":0.9918682192009556,"shares":295000000,"dividePrice":0,"high":1.03,"amplitude":0.172066,"preClose":0.9508,"low":0.8664,"week52Low":0.5031,"pbRate":"1.62","psRate":"5.04","week52High":3.0699,"institutionHeld":0,"latestPrice":0.9965,"eps":-0.36413848,"divideRate":0,"volume":5426368,"delay":0,"ttmEps":-0.36413848,"open":0.945,"prevYearClose":2.47,"prevWeekClose":0.7209,"prevMonthClose":0.535,"prevQuarterClose":0.8724,"fiveDayClose":0.7209,"twentyDayClose":0.6114,"sixtyDayClose":1.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVVD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"IVVD","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2026-05-14","symbol":"IVVD","fiscalQuarterEnding":"2026/03","expectedEps":-0.08,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-0.13},{"market":"US","date":"2026-03-05","symbol":"IVVD","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":0},{"date":"2026-01-08","symbol":"IVVD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1767862800000,"name":null,"time":"Pre-MKt","dateTimestamp":1767848400000,"actualEps":null},{"market":"US","date":"2025-11-06","symbol":"IVVD","fiscalQuarterEnding":"2025/09","expectedEps":-0.05,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVVD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVVD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1766462400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVVD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVVD","date":"2026-08-21","current":-2.736596,"percent":0.312449,"low":-54.35026,"twenty":-3.914932,"median":-1.257306,"eighty":-0.630903,"high":-0.190048,"avg":-4.062495,"sd":7.819666,"marketCap":280256615},"quantilePoints":[{"date":"2021-08-27","current":-29.442955,"twenty":-27.834156,"median":-26.254432,"eighty":-22.790669,"marketCap":3296888030},{"date":"2021-09-03","current":-41.082517,"twenty":-30.582682,"median":-26.903767,"eighty":-24.407221,"marketCap":4600233167},{"date":"2021-09-10","current":-52.237501,"twenty":-34.346884,"median":-27.107289,"eighty":-25.864831,"marketCap":5849317474},{"date":"2021-09-17","current":-49.87276,"twenty":-41.574848,"median":-28.333272,"eighty":-25.990822,"marketCap":5584524623},{"date":"2021-09-24","current":-43.437403,"twenty":-45.837563,"median":-31.3425,"eighty":-26.070293,"marketCap":4863922575},{"date":"2021-10-01","current":-27.799143,"twenty":-45.332177,"median":-32.752622,"eighty":-26.167208,"marketCap":3112821446},{"date":"2021-10-08","current":-34.098162,"twenty":-44.772716,"median":-31.663999,"eighty":-26.477338,"marketCap":3818156971},{"date":"2021-10-15","current":-32.220379,"twenty":-44.391197,"median":-31.942189,"eighty":-26.810728,"marketCap":3607891333},{"date":"2021-10-22","current":-33.531847,"twenty":-43.143316,"median":-32.796234,"eighty":-26.944471,"marketCap":3754743525},{"date":"2021-10-29","current":-29.050998,"twenty":-41.908316,"median":-32.394248,"eighty":-27.107289,"marketCap":3252998538},{"date":"2021-11-05","current":-19.910465,"twenty":-41.574848,"median":-31.842835,"eighty":-27.107289,"marketCap":2229483266},{"date":"2021-11-12","current":-19.016283,"twenty":-41.160049,"median":-31.463508,"eighty":-26.167208,"marketCap":2129356772},{"date":"2021-11-19","current":-10.754495,"twenty":-40.958465,"median":-30.898976,"eighty":-23.930397,"marketCap":2232820816},{"date":"2021-11-26","current":-13.460534,"twenty":-40.462257,"median":-30.670462,"eighty":-19.910465,"marketCap":2794641699},{"date":"2021-12-03","current":-24.557973,"twenty":-40.277958,"median":-30.278016,"eighty":-20.235974,"marketCap":5098663577},{"date":"2021-12-10","current":-17.806272,"twenty":-39.274486,"median":-29.442955,"eighty":-19.910465,"marketCap":3696892661},{"date":"2021-12-17","current":-6.15155,"twenty":-36.830387,"median":-28.396375,"eighty":-19.016283,"marketCap":1277169056},{"date":"2021-12-23","current":-4.640455,"twenty":-35.773265,"median":-28.318734,"eighty":-17.731253,"marketCap":963439375},{"date":"2021-12-31","current":-3.890266,"twenty":-34.889434,"median":-27.107289,"eighty":-10.888458,"marketCap":807687051},{"date":"2022-01-07","current":-3.177586,"twenty":-34.726181,"median":-26.845617,"eighty":-10.250797,"marketCap":659722343},{"date":"2022-01-14","current":-3.054341,"twenty":-34.716142,"median":-26.109059,"eighty":-6.024018,"marketCap":634134462},{"date":"2022-01-21","current":-3.370492,"twenty":-34.344559,"median":-25.973377,"eighty":-4.803353,"marketCap":699772941},{"date":"2022-01-28","current":-3.633058,"twenty":-33.758373,"median":-25.150086,"eighty":-4.146402,"marketCap":754286254},{"date":"2022-02-04","current":-4.41004,"twenty":-33.472235,"median":-24.833935,"eighty":-4.117466,"marketCap":915601161},{"date":"2022-02-11","current":-3.750945,"twenty":-33.414609,"median":-22.901153,"eighty":-4.037089,"marketCap":778761620},{"date":"2022-02-18","current":-3.440152,"twenty":-33.038815,"median":-20.249744,"eighty":-3.881692,"marketCap":714235657},{"date":"2022-02-25","current":-3.499096,"twenty":-32.761344,"median":-19.910465,"eighty":-3.803458,"marketCap":726473339},{"date":"2022-03-04","current":-2.695322,"twenty":-32.644704,"median":-19.383891,"eighty":-3.620198,"marketCap":559595849},{"date":"2022-03-11","current":-2.706039,"twenty":-32.425048,"median":-19.016283,"eighty":-3.495881,"marketCap":561820883},{"date":"2022-03-18","current":-2.663171,"twenty":-32.232302,"median":-18.082234,"eighty":-3.447654,"marketCap":552920750},{"date":"2022-03-25","current":-2.121963,"twenty":-32.069361,"median":-13.460534,"eighty":-3.399428,"marketCap":440556573},{"date":"2022-04-01","current":-2.185863,"twenty":-31.771301,"median":-10.864345,"eighty":-3.292258,"marketCap":495731781},{"date":"2022-04-08","current":-1.866688,"twenty":-31.632206,"median":-10.454419,"eighty":-3.196877,"marketCap":423346167},{"date":"2022-04-14","current":-1.736117,"twenty":-31.536113,"median":-10.036457,"eighty":-2.990039,"marketCap":393733871},{"date":"2022-04-22","current":-1.426614,"twenty":-31.313407,"median":-6.874947,"eighty":-2.80142,"marketCap":323541760},{"date":"2022-04-29","current":-1.38309,"twenty":-31.137425,"median":-5.513889,"eighty":-2.691035,"marketCap":313670994},{"date":"2022-05-06","current":-1.392762,"twenty":-30.873144,"median":-5.106644,"eighty":-2.665314,"marketCap":315864498},{"date":"2022-05-13","current":-1.033486,"twenty":-30.749945,"median":-4.774417,"eighty":-2.440927,"marketCap":298425270},{"date":"2022-05-20","current":-1.120876,"twenty":-30.64463,"median":-4.321625,"eighty":-2.212136,"marketCap":323659760},{"date":"2022-05-27","current":-1.132275,"twenty":-30.523419,"median":-4.206417,"eighty":-2.074048,"marketCap":326951215},{"date":"2022-06-03","current":-1.200668,"twenty":-30.451885,"median":-4.15819,"eighty":-1.963408,"marketCap":346699946},{"date":"2022-06-10","current":-1.124676,"twenty":-30.104147,"median":-3.970643,"eighty":-1.784476,"marketCap":324756912},{"date":"2022-06-17","current":-1.033486,"twenty":-30.05447,"median":-3.890266,"eighty":-1.562021,"marketCap":298425270},{"date":"2022-06-24","current":-1.27695,"twenty":-29.565258,"median":-3.847398,"eighty":-1.481744,"marketCap":368726981},{"date":"2022-07-01","current":-1.330156,"twenty":-29.129389,"median":-3.775058,"eighty":-1.43822,"marketCap":384090605},{"date":"2022-07-08","current":-1.569584,"twenty":-28.687364,"median":-3.66253,"eighty":-1.432587,"marketCap":453226914},{"date":"2022-07-15","current":-1.527779,"twenty":-28.386662,"median":-3.584832,"eighty":-1.439301,"marketCap":441155495},{"date":"2022-07-22","current":-1.580986,"twenty":-28.330364,"median":-3.496417,"eighty":-1.441122,"marketCap":456519119},{"date":"2022-07-29","current":-1.337757,"twenty":-28.318734,"median":-3.466945,"eighty":-1.439301,"marketCap":386285408},{"date":"2022-08-05","current":-1.520179,"twenty":-28.006979,"median":-3.442832,"eighty":-1.418008,"marketCap":438960692},{"date":"2022-08-12","current":-1.516378,"twenty":-27.384031,"median":-3.402643,"eighty":-1.425167,"marketCap":437863290},{"date":"2022-08-19","current":-1.549068,"twenty":-27.107289,"median":-3.34102,"eighty":-1.426035,"marketCap":457088205},{"date":"2022-08-26","current":-1.69291,"twenty":-26.985176,"median":-3.279398,"eighty":-1.431485,"marketCap":499532109},{"date":"2022-09-02","current":-1.762987,"twenty":-26.833988,"median":-3.247247,"eighty":-1.435834,"marketCap":520209909},{"date":"2022-09-09","current":-1.696599,"twenty":-26.632403,"median":-3.150793,"eighty":-1.43839,"marketCap":500620415},{"date":"2022-09-16","current":-1.416291,"twenty":-26.283507,"median":-2.973964,"eighty":-1.43839,"marketCap":417909216},{"date":"2022-09-23","current":-1.095413,"twenty":-26.089676,"median":-2.842681,"eighty":-1.425167,"marketCap":323226659},{"date":"2022-09-30","current":-1.166035,"twenty":-26.025711,"median":-2.786416,"eighty":-1.403926,"marketCap":344065403},{"date":"2022-10-07","current":-1.188387,"twenty":-25.919104,"median":-2.692642,"eighty":-1.367291,"marketCap":350660906},{"date":"2022-10-14","current":-1.221915,"twenty":-25.585157,"median":-2.679246,"eighty":-1.335295,"marketCap":360554160},{"date":"2022-10-21","current":-1.370929,"twenty":-25.161339,"median":-2.598869,"eighty":-1.327097,"marketCap":404524180},{"date":"2022-10-28","current":-1.464063,"twenty":-25.020946,"median":-2.452181,"eighty":-1.331555,"marketCap":432005442},{"date":"2022-11-04","current":-1.318774,"twenty":-24.880554,"median":-2.304152,"eighty":-1.330032,"marketCap":389134673},{"date":"2022-11-11","current":-1.402279,"twenty":-24.72355,"median":-2.205207,"eighty":-1.330032,"marketCap":392336643},{"date":"2022-11-18","current":-1.071185,"twenty":-24.116213,"median":-2.120061,"eighty":-1.321288,"marketCap":299701602},{"date":"2022-11-25","current":-0.833577,"twenty":-23.232604,"median":-2.052303,"eighty":-1.304144,"marketCap":233222338},{"date":"2022-12-02","current":-0.903691,"twenty":-22.029676,"median":-1.963408,"eighty":-1.287526,"marketCap":252839170},{"date":"2022-12-09","current":-0.771253,"twenty":-20.652703,"median":-1.869106,"eighty":-1.273678,"marketCap":215785153},{"date":"2022-12-16","current":-0.631026,"twenty":-20.24699,"median":-1.781428,"eighty":-1.254406,"marketCap":176551489},{"date":"2022-12-23","current":-0.662187,"twenty":-20.170872,"median":-1.761143,"eighty":-1.246835,"marketCap":185270081},{"date":"2022-12-30","current":-0.584283,"twenty":-19.910465,"median":-1.729267,"eighty":-1.233091,"marketCap":163473601},{"date":"2023-01-06","current":-0.646606,"twenty":-19.910465,"median":-1.709507,"eighty":-1.220425,"marketCap":180910785},{"date":"2023-01-13","current":-0.864739,"twenty":-19.727655,"median":-1.700287,"eighty":-1.204982,"marketCap":241940930},{"date":"2023-01-20","current":-0.705035,"twenty":-19.324279,"median":-1.696599,"eighty":-1.18418,"marketCap":197258145},{"date":"2023-01-27","current":-0.966014,"twenty":-19.073908,"median":-1.680001,"eighty":-1.168577,"marketCap":270276354},{"date":"2023-02-03","current":-0.817996,"twenty":-19.036154,"median":-1.663404,"eighty":-1.145789,"marketCap":228863042},{"date":"2023-02-10","current":-0.697244,"twenty":-18.849703,"median":-1.652339,"eighty":-1.126955,"marketCap":195078497},{"date":"2023-02-17","current":-0.759568,"twenty":-18.510377,"median":-1.599988,"eighty":-1.120876,"marketCap":212515681},{"date":"2023-02-24","current":-0.669978,"twenty":-18.137426,"median":-1.580986,"eighty":-1.092453,"marketCap":187449729},{"date":"2023-03-03","current":-0.681663,"twenty":-17.656234,"median":-1.570639,"eighty":-1.028927,"marketCap":190719201},{"date":"2023-03-10","current":-0.689454,"twenty":-15.84292,"median":-1.562021,"eighty":-1.00081,"marketCap":192898849},{"date":"2023-03-17","current":-0.588178,"twenty":-12.481002,"median":-1.538592,"eighty":-0.965462,"marketCap":164563425},{"date":"2023-03-24","current":-0.592742,"twenty":-10.968835,"median":-1.527779,"eighty":-0.894342,"marketCap":143038670},{"date":"2023-03-31","current":-0.54297,"twenty":-10.872382,"median":-1.517437,"eighty":-0.884215,"marketCap":131027790},{"date":"2023-04-06","current":-0.538445,"twenty":-10.810224,"median":-1.510673,"eighty":-0.88032,"marketCap":129935891},{"date":"2023-04-14","current":-0.534538,"twenty":-10.69448,"median":-1.497376,"eighty":-0.857727,"marketCap":128993146},{"date":"2023-04-21","current":-0.539068,"twenty":-10.424412,"median":-1.489775,"eighty":-0.829682,"marketCap":130086308},{"date":"2023-04-28","current":-0.511888,"twenty":-10.250797,"median":-1.484646,"eighty":-0.81488,"marketCap":123527335},{"date":"2023-05-05","current":-0.534538,"twenty":-10.004306,"median":-1.471564,"eighty":-0.788392,"marketCap":128993146},{"date":"2023-05-12","current":-0.888336,"twenty":-9.42023,"median":-1.465302,"eighty":-0.768137,"marketCap":156322203},{"date":"2023-05-19","current":-0.777692,"twenty":-7.308984,"median":-1.45367,"eighty":-0.771253,"marketCap":136852082},{"date":"2023-05-26","current":-0.914566,"twenty":-6.075459,"median":-1.441122,"eighty":-0.771297,"marketCap":160938049},{"date":"2023-06-02","current":-0.933231,"twenty":-5.771097,"median":-1.436569,"eighty":-0.771471,"marketCap":164222499},{"date":"2023-06-09","current":-0.839908,"twenty":-5.513889,"median":-1.428574,"eighty":-0.777692,"marketCap":147800249},{"date":"2023-06-16","current":-0.796357,"twenty":-5.358493,"median":-1.425167,"eighty":-0.783914,"marketCap":140136532},{"date":"2023-06-23","current":-0.659483,"twenty":-5.277043,"median":-1.40727,"eighty":-0.771253,"marketCap":116050565},{"date":"2023-06-30","current":-0.703034,"twenty":-5.076636,"median":-1.402434,"eighty":-0.766514,"marketCap":123714282},{"date":"2023-07-07","current":-0.696812,"twenty":-4.903021,"median":-1.400732,"eighty":-0.759568,"marketCap":122619465},{"date":"2023-07-14","current":-0.858572,"twenty":-4.803353,"median":-1.392762,"eighty":-0.759568,"marketCap":151084699},{"date":"2023-07-21","current":-0.902123,"twenty":-4.720832,"median":-1.38309,"eighty":-0.76184,"marketCap":158748415},{"date":"2023-07-28","current":-0.902123,"twenty":-4.548289,"median":-1.369067,"eighty":-0.766093,"marketCap":158748415},{"date":"2023-08-04","current":-0.920788,"twenty":-4.339308,"median":-1.356759,"eighty":-0.767358,"marketCap":162032865},{"date":"2023-08-11","current":-0.964339,"twenty":-4.226779,"median":-1.354805,"eighty":-0.768916,"marketCap":169696582},{"date":"2023-08-18","current":-1.071184,"twenty":-4.212847,"median":-1.341126,"eighty":-0.771253,"marketCap":187682117},{"date":"2023-08-25","current":-1.115033,"twenty":-4.206417,"median":-1.331904,"eighty":-0.77134,"marketCap":195365010},{"date":"2023-09-01","current":-1.165147,"twenty":-4.187126,"median":-1.325058,"eighty":-0.771471,"marketCap":204145460},{"date":"2023-09-08","current":-1.108769,"twenty":-4.137828,"median":-1.318774,"eighty":-0.772715,"marketCap":194267454},{"date":"2023-09-15","current":-1.102505,"twenty":-4.046734,"median":-1.300575,"eighty":-0.778936,"marketCap":193169898},{"date":"2023-09-22","current":-1.039863,"twenty":-3.993149,"median":-1.292152,"eighty":-0.783914,"marketCap":182194335},{"date":"2023-09-29","current":-1.108769,"twenty":-3.92456,"median":-1.28265,"eighty":-0.784498,"marketCap":194267454},{"date":"2023-10-06","current":-1.02107,"twenty":-3.890266,"median":-1.27286,"eighty":-0.788392,"marketCap":178901667},{"date":"2023-10-13","current":-1.033598,"twenty":-3.885979,"median":-1.257306,"eighty":-0.794625,"marketCap":181096779},{"date":"2023-10-20","current":-0.989749,"twenty":-3.864545,"median":-1.253862,"eighty":-0.794971,"marketCap":173413885},{"date":"2023-10-27","current":-1.039863,"twenty":-3.855972,"median":-1.250062,"eighty":-0.795664,"marketCap":182194335},{"date":"2023-11-03","current":-0.970956,"twenty":-3.824892,"median":-1.24107,"eighty":-0.80009,"marketCap":170121217},{"date":"2023-11-10","current":-0.876993,"twenty":-3.803458,"median":-1.233091,"eighty":-0.803649,"marketCap":153657873},{"date":"2023-11-17","current":-0.974107,"twenty":-3.770235,"median":-1.223778,"eighty":-0.807025,"marketCap":165172440},{"date":"2023-11-24","current":-0.967613,"twenty":-3.727368,"median":-1.213951,"eighty":-0.8088,"marketCap":164071290},{"date":"2023-12-01","current":-0.993589,"twenty":-3.668424,"median":-1.20606,"eighty":-0.8088,"marketCap":168475888},{"date":"2023-12-08","current":-1.097493,"twenty":-3.624484,"median":-1.192112,"eighty":-0.81092,"marketCap":186094282},{"date":"2023-12-15","current":-1.116976,"twenty":-3.600907,"median":-1.17787,"eighty":-0.815659,"marketCap":189397731},{"date":"2023-12-22","current":-2.435267,"twenty":-3.563398,"median":-1.186164,"eighty":-0.817996,"marketCap":412931100},{"date":"2023-12-29","current":-2.545665,"twenty":-3.531247,"median":-1.195838,"eighty":-0.817996,"marketCap":431650643},{"date":"2024-01-05","current":-2.435267,"twenty":-3.511956,"median":-1.203364,"eighty":-0.820333,"marketCap":412931100},{"date":"2024-01-12","current":-2.688534,"twenty":-3.495881,"median":-1.213437,"eighty":-0.826566,"marketCap":455875934},{"date":"2024-01-19","current":-2.883356,"twenty":-3.48945,"median":-1.221915,"eighty":-0.829682,"marketCap":488910422},{"date":"2024-01-26","current":-2.876862,"twenty":-3.47659,"median":-1.233091,"eighty":-0.83124,"marketCap":487809272},{"date":"2024-02-02","current":-3.117141,"twenty":-3.460515,"median":-1.235593,"eighty":-0.833621,"marketCap":528551808},{"date":"2024-02-09","current":-3.272998,"twenty":-3.448726,"median":-1.249027,"eighty":-0.836175,"marketCap":554979398},{"date":"2024-02-16","current":-2.88069,"twenty":-3.448726,"median":-1.254147,"eighty":-0.839908,"marketCap":488458412},{"date":"2024-02-23","current":-2.831627,"twenty":-3.444439,"median":-1.259169,"eighty":-0.842397,"marketCap":480139169},{"date":"2024-03-01","current":-2.754528,"twenty":-3.436937,"median":-1.274905,"eighty":-0.852491,"marketCap":467066072},{"date":"2024-03-08","current":-2.670421,"twenty":-3.41979,"median":-1.284551,"eighty":-0.853832,"marketCap":452804513},{"date":"2024-03-15","current":-2.558277,"twenty":-3.401571,"median":-1.29463,"eighty":-0.857273,"marketCap":433789100},{"date":"2024-03-22","current":-2.165774,"twenty":-3.391926,"median":-1.301003,"eighty":-0.858572,"marketCap":367235156},{"date":"2024-03-28","current":-2.393164,"twenty":-3.370492,"median":-1.318774,"eighty":-0.858572,"marketCap":475385316},{"date":"2024-04-05","current":-2.148639,"twenty":-3.311549,"median":-1.327504,"eighty":-0.860844,"marketCap":426812003},{"date":"2024-04-12","current":-1.833545,"twenty":-3.311549,"median":-1.333653,"eighty":-0.864739,"marketCap":364220857},{"date":"2024-04-19","current":-1.410419,"twenty":-3.279398,"median":-1.341342,"eighty":-0.864794,"marketCap":280169890},{"date":"2024-04-26","current":-1.242369,"twenty":-3.274039,"median":-1.341126,"eighty":-0.864794,"marketCap":246787946},{"date":"2024-05-03","current":-1.422423,"twenty":-3.272998,"median":-1.339441,"eighty":-0.864794,"marketCap":282554315},{"date":"2024-05-10","current":-1.452432,"twenty":-3.268681,"median":-1.354074,"eighty":-0.871015,"marketCap":288515376},{"date":"2024-05-17","current":-1.412314,"twenty":-3.26001,"median":-1.355782,"eighty":-0.876993,"marketCap":292092013},{"date":"2024-05-24","current":-1.158674,"twenty":-3.225813,"median":-1.354074,"eighty":-0.877237,"marketCap":239634672},{"date":"2024-05-31","current":-1.043383,"twenty":-3.211609,"median":-1.341126,"eighty":-0.879703,"marketCap":215790426},{"date":"2024-06-07","current":-1.009596,"twenty":-3.192472,"median":-1.333025,"eighty":-0.88032,"marketCap":208802627},{"date":"2024-06-14","current":-0.98075,"twenty":-3.181982,"median":-1.330053,"eighty":-0.88032,"marketCap":202836837},{"date":"2024-06-21","current":-0.755755,"twenty":-3.174189,"median":-1.321916,"eighty":-0.87847,"marketCap":156303680},{"date":"2024-06-28","current":-0.692294,"twenty":-3.170792,"median":-1.318774,"eighty":-0.877188,"marketCap":143178944},{"date":"2024-07-05","current":-0.634603,"twenty":-3.142038,"median":-1.315549,"eighty":-0.864794,"marketCap":131247365},{"date":"2024-07-12","current":-0.674987,"twenty":-3.119885,"median":-1.301003,"eighty":-0.859935,"marketCap":139599470},{"date":"2024-07-15","current":-0.686525,"twenty":-3.118513,"median":-1.300575,"eighty":-0.858572,"marketCap":141985786},{"date":"2024-08-02","current":-0.68941,"twenty":-3.117141,"median":-1.300147,"eighty":-0.858572,"marketCap":142582365},{"date":"2024-08-09","current":-0.605758,"twenty":-3.097659,"median":-1.294588,"eighty":-0.848061,"marketCap":125281576},{"date":"2024-08-16","current":-0.60941,"twenty":-3.065189,"median":-1.28637,"eighty":-0.833577,"marketCap":124220340},{"date":"2024-08-23","current":-0.514541,"twenty":-3.055914,"median":-1.279565,"eighty":-0.817996,"marketCap":104882577},{"date":"2024-08-30","current":-0.517764,"twenty":-3.054341,"median":-1.273965,"eighty":-0.8088,"marketCap":105539512},{"date":"2024-09-06","current":-0.498896,"twenty":-3.052629,"median":-1.268761,"eighty":-0.804006,"marketCap":101693459},{"date":"2024-09-13","current":-0.673867,"twenty":-3.052201,"median":-1.254795,"eighty":-0.793067,"marketCap":137359030},{"date":"2024-09-20","current":-0.714885,"twenty":-3.043957,"median":-1.250062,"eighty":-0.776448,"marketCap":145720014},{"date":"2024-09-27","current":-0.60941,"twenty":-3.030682,"median":-1.247269,"eighty":-0.770474,"marketCap":124220340},{"date":"2024-10-04","current":-0.562884,"twenty":-3.005449,"median":-1.242369,"eighty":-0.759568,"marketCap":114736595},{"date":"2024-10-11","current":-0.529894,"twenty":-2.97914,"median":-1.234118,"eighty":-0.750739,"marketCap":108011974},{"date":"2024-10-18","current":-0.61527,"twenty":-2.95253,"median":-1.22564,"eighty":-0.739313,"marketCap":125414766},{"date":"2024-10-25","current":-0.57935,"twenty":-2.944451,"median":-1.213951,"eighty":-0.734142,"marketCap":118092933},{"date":"2024-10-31","current":-0.533292,"twenty":-2.934797,"median":-1.206537,"eighty":-0.729185,"marketCap":108704742},{"date":"2024-11-08","current":-0.585971,"twenty":-2.925172,"median":-1.195838,"eighty":-0.709709,"marketCap":119442635},{"date":"2024-11-15","current":-0.419997,"twenty":-2.922744,"median":-1.180905,"eighty":-0.703113,"marketCap":94556475},{"date":"2024-11-22","current":-0.371808,"twenty":-2.92249,"median":-1.17407,"eighty":-0.697071,"marketCap":83707301},{"date":"2024-11-29","current":-0.37117,"twenty":-2.91193,"median":-1.166035,"eighty":-0.69059,"marketCap":83563762},{"date":"2024-12-06","current":-0.303269,"twenty":-2.891149,"median":-1.165147,"eighty":-0.68557,"marketCap":68276832},{"date":"2024-12-13","current":-0.308104,"twenty":-2.88229,"median":-1.162672,"eighty":-0.679326,"marketCap":69365338},{"date":"2024-12-20","current":-0.228302,"twenty":-2.879159,"median":-1.158778,"eighty":-0.673873,"marketCap":51399010},{"date":"2024-12-27","current":-0.281805,"twenty":-2.876862,"median":-1.150014,"eighty":-0.673867,"marketCap":63444344},{"date":"2025-01-03","current":-0.255027,"twenty":-2.876862,"median":-1.146355,"eighty":-0.669978,"marketCap":57415696},{"date":"2025-01-10","current":-0.245198,"twenty":-2.874317,"median":-1.138593,"eighty":-0.663197,"marketCap":55202800},{"date":"2025-01-17","current":-0.233403,"twenty":-2.868171,"median":-1.132275,"eighty":-0.656796,"marketCap":52547324},{"date":"2025-01-24","current":-0.222245,"twenty":-2.85831,"median":-1.128781,"eighty":-0.646866,"marketCap":50035387},{"date":"2025-01-31","current":-0.207209,"twenty":-2.840038,"median":-1.124676,"eighty":-0.643039,"marketCap":46650253},{"date":"2025-02-07","current":-1.051985,"twenty":-2.823791,"median":-1.121298,"eighty":-0.64111,"marketCap":236839749},{"date":"2025-02-14","current":-0.733202,"twenty":-2.818476,"median":-1.120876,"eighty":-0.643039,"marketCap":165070128},{"date":"2025-02-21","current":-0.64288,"twenty":-2.812485,"median":-1.118477,"eighty":-0.643031,"marketCap":144735402},{"date":"2025-02-28","current":-0.658819,"twenty":-2.803591,"median":-1.116976,"eighty":-0.644411,"marketCap":148323883},{"date":"2025-03-07","current":-0.547245,"twenty":-2.801008,"median":-1.110663,"eighty":-0.636245,"marketCap":123204516},{"date":"2025-03-14","current":-0.431473,"twenty":-2.796913,"median":-1.108769,"eighty":-0.631096,"marketCap":97140182},{"date":"2025-03-21","current":-0.521427,"twenty":-2.792516,"median":-1.102505,"eighty":-0.62713,"marketCap":88603523},{"date":"2025-03-28","current":-0.43064,"twenty":-2.784875,"median":-1.097493,"eighty":-0.619015,"marketCap":73176481},{"date":"2025-04-04","current":-0.388282,"twenty":-2.77135,"median":-1.096241,"eighty":-0.613037,"marketCap":65978794},{"date":"2025-04-11","current":-0.356513,"twenty":-2.754107,"median":-1.09048,"eighty":-0.611536,"marketCap":60580529},{"date":"2025-04-17","current":-0.332722,"twenty":-2.752176,"median":-1.083864,"eighty":-0.609696,"marketCap":56537829},{"date":"2025-04-25","current":-0.471868,"twenty":-2.738793,"median":-1.080862,"eighty":-0.606488,"marketCap":80182229},{"date":"2025-05-02","current":-0.428663,"twenty":-2.703896,"median":-1.071184,"eighty":-0.598126,"marketCap":72840589},{"date":"2025-05-09","current":-0.416521,"twenty":-2.69425,"median":-1.060024,"eighty":-0.594913,"marketCap":70777252},{"date":"2025-05-16","current":-0.591746,"twenty":-2.689677,"median":-1.057662,"eighty":-0.591763,"marketCap":84452857},{"date":"2025-05-23","current":-0.639237,"twenty":-2.687748,"median":-1.049056,"eighty":-0.592013,"marketCap":91230678},{"date":"2025-05-30","current":-0.712617,"twenty":-2.684605,"median":-1.046127,"eighty":-0.592742,"marketCap":101703313},{"date":"2025-06-06","current":-0.777592,"twenty":-2.679246,"median":-1.043383,"eighty":-0.594219,"marketCap":110976332},{"date":"2025-06-13","current":-0.711777,"twenty":-2.677429,"median":-1.039863,"eighty":-0.597691,"marketCap":101583351},{"date":"2025-06-20","current":-0.629571,"twenty":-2.675923,"median":-1.039153,"eighty":-0.597691,"marketCap":89851122},{"date":"2025-06-27","current":-0.671514,"twenty":-2.67422,"median":-1.033598,"eighty":-0.596997,"marketCap":95837198},{"date":"2025-07-03","current":-0.617887,"twenty":-2.671808,"median":-1.033598,"eighty":-0.597691,"marketCap":88183658},{"date":"2025-07-11","current":-0.626545,"twenty":-2.667044,"median":-1.033598,"eighty":-0.597691,"marketCap":89419261},{"date":"2025-07-18","current":-0.606624,"twenty":-2.663819,"median":-1.033486,"eighty":-0.596302,"marketCap":86576174},{"date":"2025-07-25","current":-0.680845,"twenty":-2.662803,"median":-1.027334,"eighty":-0.597691,"marketCap":97168770},{"date":"2025-08-01","current":-0.583341,"twenty":-2.658865,"median":-1.025887,"eighty":-0.597691,"marketCap":83253242},{"date":"2025-08-08","current":-0.633438,"twenty":-2.628925,"median":-1.018217,"eighty":-0.597691,"marketCap":90402944},{"date":"2025-08-15","current":-0.671851,"twenty":-2.608646,"median":-1.01456,"eighty":-0.597691,"marketCap":95885182},{"date":"2025-08-22","current":-0.57589,"twenty":-2.594724,"median":-1.009192,"eighty":-0.597691,"marketCap":63423389},{"date":"2025-08-29","current":-1.752501,"twenty":-2.586313,"median":-1.009596,"eighty":-0.598995,"marketCap":193004672},{"date":"2025-09-05","current":-1.765777,"twenty":-2.577902,"median":-1.01456,"eighty":-0.600315,"marketCap":194466829},{"date":"2025-09-12","current":-2.17735,"twenty":-2.562482,"median":-1.018217,"eighty":-0.601664,"marketCap":239793684},{"date":"2025-09-19","current":-2.212754,"twenty":-2.555269,"median":-1.025887,"eighty":-0.603107,"marketCap":243692768},{"date":"2025-09-26","current":-2.018031,"twenty":-2.548721,"median":-1.027334,"eighty":-0.604535,"marketCap":222247805},{"date":"2025-10-03","current":-2.159648,"twenty":-2.542299,"median":-1.033486,"eighty":-0.605723,"marketCap":237844142},{"date":"2025-10-10","current":-3.345683,"twenty":-2.555269,"median":-1.033598,"eighty":-0.605758,"marketCap":368463466},{"date":"2025-10-17","current":-3.407002,"twenty":-2.598929,"median":-1.033598,"eighty":-0.605936,"marketCap":375216537},{"date":"2025-10-24","current":-3.776905,"twenty":-2.662926,"median":-1.033598,"eighty":-0.606372,"marketCap":415954333},{"date":"2025-10-31","current":-3.640625,"twenty":-2.674883,"median":-1.039863,"eighty":-0.607081,"marketCap":400945671},{"date":"2025-11-07","current":-5.515862,"twenty":-2.686962,"median":-1.039863,"eighty":-0.608117,"marketCap":330190553},{"date":"2025-11-14","current":-6.892977,"twenty":-2.717777,"median":-1.044211,"eighty":-0.608949,"marketCap":412627416},{"date":"2025-11-21","current":-9.34641,"twenty":-2.77135,"median":-1.046127,"eighty":-0.60941,"marketCap":559494801},{"date":"2025-11-28","current":-9.46324,"twenty":-2.797023,"median":-1.052188,"eighty":-0.60941,"marketCap":566488486},{"date":"2025-12-05","current":-8.645429,"twenty":-2.818537,"median":-1.058529,"eighty":-0.60941,"marketCap":517532691},{"date":"2025-12-12","current":-9.268523,"twenty":-2.872304,"median":-1.063219,"eighty":-0.60966,"marketCap":554832344},{"date":"2025-12-19","current":-8.918033,"twenty":-2.882823,"median":-1.071185,"eighty":-0.610693,"marketCap":533851289},{"date":"2025-12-26","current":-10.943088,"twenty":-2.903133,"median":-1.083712,"eighty":-0.610827,"marketCap":655075163},{"date":"2026-01-02","current":-9.619014,"twenty":-2.923958,"median":-1.083864,"eighty":-0.610838,"marketCap":575813399},{"date":"2026-01-09","current":-11.619697,"twenty":-2.97914,"median":-1.092947,"eighty":-0.610897,"marketCap":695578313},{"date":"2026-01-16","current":-11.493909,"twenty":-3.052201,"median":-1.096241,"eighty":-0.611404,"marketCap":688048360},{"date":"2026-01-23","current":-10.410466,"twenty":-3.059624,"median":-1.097493,"eighty":-0.611527,"marketCap":623191342},{"date":"2026-01-30","current":-8.714644,"twenty":-3.119885,"median":-1.102505,"eighty":-0.61154,"marketCap":521676011},{"date":"2026-02-06","current":-8.055157,"twenty":-3.175062,"median":-1.108769,"eighty":-0.611549,"marketCap":482197826},{"date":"2026-02-13","current":-7.207246,"twenty":-3.239492,"median":-1.110663,"eighty":-0.611549,"marketCap":431440160},{"date":"2026-02-20","current":-7.584095,"twenty":-3.273623,"median":-1.116004,"eighty":-0.611549,"marketCap":453999123},{"date":"2026-02-27","current":-8.008051,"twenty":-3.321408,"median":-1.117077,"eighty":-0.611697,"marketCap":479377956},{"date":"2026-03-06","current":-9.347815,"twenty":-3.393384,"median":-1.120876,"eighty":-0.61326,"marketCap":490657437},{"date":"2026-03-13","current":-9.690993,"twenty":-3.417247,"median":-1.121298,"eighty":-0.61527,"marketCap":508670512},{"date":"2026-03-20","current":-7.806633,"twenty":-3.448726,"median":-1.124676,"eighty":-0.615376,"marketCap":409762357},{"date":"2026-03-27","current":-8.129666,"twenty":-3.492431,"median":-1.128781,"eighty":-0.615752,"marketCap":426718040},{"date":"2026-04-02","current":-7.160567,"twenty":-3.574115,"median":-1.132275,"eighty":-0.616125,"marketCap":375850989},{"date":"2026-04-10","current":-9.590407,"twenty":-3.639112,"median":-1.138593,"eighty":-0.616629,"marketCap":503390876},{"date":"2026-04-17","current":-9.213256,"twenty":-3.771713,"median":-1.146355,"eighty":-0.617887,"marketCap":483594605},{"date":"2026-04-24","current":-8.135682,"twenty":-3.844981,"median":-1.155647,"eighty":-0.618459,"marketCap":427033833},{"date":"2026-05-01","current":-7.543017,"twenty":-3.92456,"median":-1.158883,"eighty":-0.621178,"marketCap":395925408},{"date":"2026-05-08","current":-7.704653,"twenty":-4.113148,"median":-1.165147,"eighty":-0.62294,"marketCap":404409524},{"date":"2026-05-15","current":-6.249928,"twenty":-4.206417,"median":-1.165489,"eighty":-0.623761,"marketCap":328052481},{"date":"2026-05-22","current":-4.214101,"twenty":-4.212564,"median":-1.172171,"eighty":-0.626629,"marketCap":327014271},{"date":"2026-05-29","current":-4.290031,"twenty":-4.217134,"median":-1.177541,"eighty":-0.626965,"marketCap":332906420},{"date":"2026-06-05","current":-4.214101,"twenty":-4.290031,"median":-1.188387,"eighty":-0.62713,"marketCap":327014271},{"date":"2026-06-12","current":-3.084646,"twenty":-4.233209,"median":-1.203364,"eighty":-0.62713,"marketCap":239368554},{"date":"2026-06-18","current":-3.535289,"twenty":-4.220349,"median":-1.210225,"eighty":-0.62713,"marketCap":274338459},{"date":"2026-06-26","current":-3.336353,"twenty":-4.214708,"median":-1.221915,"eighty":-0.62713,"marketCap":258901028},{"date":"2026-07-02","current":-3.243719,"twenty":-4.214101,"median":-1.233091,"eighty":-0.627838,"marketCap":251712606},{"date":"2026-07-10","current":-3.051237,"twenty":-4.209491,"median":-1.235369,"eighty":-0.628624,"marketCap":236776009},{"date":"2026-07-17","current":-2.991253,"twenty":-4.206417,"median":-1.245142,"eighty":-0.629024,"marketCap":232121211},{"date":"2026-07-24","current":-2.31282,"twenty":-4.194014,"median":-1.248182,"eighty":-0.629403,"marketCap":179474859},{"date":"2026-07-31","current":-2.208037,"twenty":-4.181902,"median":-1.251962,"eighty":-0.629907,"marketCap":171343694},{"date":"2026-08-07","current":-2.501885,"twenty":-4.176137,"median":-1.257306,"eighty":-0.630903,"marketCap":194146310},{"date":"2026-08-14","current":-2.604589,"twenty":-4.068733,"median":-1.257306,"eighty":-0.630903,"marketCap":202116072},{"date":"2026-08-21","current":-2.611095,"twenty":-3.914932,"median":-1.257306,"eighty":-0.630903,"marketCap":280256615}],"updateTime":1787449225508},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVVD\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2626186781","title":"Invivyd expands Phase 3 VYD2311 COVID prevention trial, shifts results to Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186781?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:04","pubTimestamp":1775732641,"startTime":"0","endTime":"0","summary":"Invivyd flagged progress in Phase 3 DECLARATION trial for COVID-19 antibody candidate VYD2311, citing event accumulation that it believes already supports anticipated efficacy range; no results have been presented.Trial expanded by about 500 additional subjects, shifting expected top-line timing to Q3 2026 from prior mid-year 2026 guidance.FDA alignment reached on initial Pediatric Study Plan for BLA-directed DRUMMER immunobridging and safety study in children ages 0-11, contingent on a successful DECLARATION readout.Pipeline broadened with advancement of VMS063, measles monoclonal antibody candidate for treatment or prevention, with IND-enabling work started and IND readiness targeted for late 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDLkT3ht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","IVVD","IE00B64PRP62.GBP","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626418648","title":"Invivyd Announces Revolution Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate Vms063 for Treatment and Prevention of Measles","url":"https://stock-news.laohu8.com/highlight/detail?id=2626418648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626418648?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:01","pubTimestamp":1775732473,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0UP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601366","title":"Invivyd announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601366","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625601366?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:20","pubTimestamp":1775506824,"startTime":"0","endTime":"0","summary":"Invivyd scheduled 2026 annual shareholder meeting for May 19, 2026, to be held virtually.Shareholders set to vote on election of six directors for one-year terms expiring at 2027 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invivyd Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL9ZN6Xw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676887","title":"Invivyd grants inducement stock options for 1.1 million shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676887","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676887?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:01","pubTimestamp":1775473299,"startTime":"0","endTime":"0","summary":"Invivyd granted stock options covering 1,083,750 shares to 16 newly hired non-executive employees on April 1, 2026.Options carry an exercise price of $1.33 per share.Vesting schedule spans four years, with 25% vesting on first anniversary of employee start date.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDL3bZk2F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014039.USD","BK4139","IE00BGHQF748.EUR","IVVD","IE00BN0W2V16.EUR","LU2210149790.SGD","LU2095319765.USD","LU2210150020.SGD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","SG9999014013.SGD","BK4585","SG9999014021.USD","IE00BN0W2T93.GBP","BK4539","IE00BKPKM429.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625067502","title":"Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625067502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625067502?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:01","pubTimestamp":1775473260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nTUA7ZQYT8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623432985","title":"Invivyd CSO presents monoclonal antibody development at World Vaccine Congress Washington","url":"https://stock-news.laohu8.com/highlight/detail?id=2623432985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623432985?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:09","pubTimestamp":1774901356,"startTime":"0","endTime":"0","summary":"Invivyd attended World Vaccine Congress Washington, presenting in Antibodies for Infectious Disease Workshop.Chief Scientific Officer Robert Allen delivered talk on developing monoclonal antibody therapies that keep pace with rapidly evolving viral threats, highlighting Invivyd platform focus on addressing virus variation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL3V4ql9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623832672","title":"Invivyd Announces Presentation at the World Vaccine Congress Washington","url":"https://stock-news.laohu8.com/highlight/detail?id=2623832672","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623832672?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:05","pubTimestamp":1774901100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUATVDHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621773948","title":"Cantor Fitzgerald Remains a Buy on Invivyd (IVVD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621773948","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621773948?lang=en_us&edition=fundamental","pubTime":"2026-03-23 15:48","pubTimestamp":1774252135,"startTime":"0","endTime":"0","summary":"In a report released on March 19, Joshua Schimmer from Cantor Fitzgerald maintained a Buy rating on Invivyd, with a price target of $10.00. The com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-invivyd-ivvd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-remains-a-buy-on-invivyd-ivvd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617154496","title":"Invivyd reports cash, cash equivalents of $226.7M as of December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2617154496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617154496?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:20","pubTimestamp":1772713254,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents were $226.7 million as of December 31, 2025. In the second half of 2025, Invivyd (IVVD) secured over $200 million of capi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-reports-cash-cash-equivalents-of-226-7m-as-of-december-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-reports-cash-cash-equivalents-of-226-7m-as-of-december-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617449935","title":"Invivyd appoints Michael Mina as CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2617449935","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617449935?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:20","pubTimestamp":1772713237,"startTime":"0","endTime":"0","summary":"Invivyd (IVVD) announced the appointment of Michael Mina, M.D., Ph.D., as Chief Medical Officer. Mina is a former assistant professor at the Harvar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-appoints-michael-mina-as-cmo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-appoints-michael-mina-as-cmo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVVD","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617054435","title":"Invivyd FY revenue rises; operating expenses cut sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=2617054435","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617054435?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:17","pubTimestamp":1772713071,"startTime":"0","endTime":"0","summary":"Invivyd FY revenue rises; operating expenses cut sharplyOverviewBiopharmaceutical company reported Q4 PEMGARDA net product revenue up 25% yr/yrLoss per share for 2025 beat analyst expectationsNet loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL1N3ZT0KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVVD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617541127","title":"BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541127","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541127?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712225,"startTime":"0","endTime":"0","summary":"BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39\n\n\nMar 05 (Reuters) - Invivyd FY revenue USD 53.426 million.\n\nFY net income USD -52.489 million vs. IBES estimate USD -57.8 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX537BEB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617541233","title":"Invivyd Q4 net product revenue rises 31% to USD 17.2 million in Q4 2025 earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541233","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541233?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712225,"startTime":"0","endTime":"0","summary":"Invivyd said Q4 2025 net product revenue from PEMGARDA was USD 17.2 million, up 25% YoY and 31% QoQ. For FY 2025, PEMGARDA net product revenue was USD 53.4 million. The company reported a FY 2025 net loss of USD 52.5 million, or USD 0.30 per share, and ended 2025 with cash and cash equivalents of USD 226.7 million after raising over USD 200 million in 2H 2025. FY 2025 R&D expenses were USD 38.3 million and SG&A expenses were USD 66.9 million. On business updates, Invivyd said its DECLARATION Phase 3 pivotal trial of VYD2311 to prevent COVID is fully enrolled, with top-line data expected mid-2026; the FDA granted Fast Track designation for VYD2311 in December 2025. The trial’s IDMC recommended allowing enrollment of pregnant and breastfeeding women, removed contraception requirements for women of childbearing age, and said certain protocol-specified safety visits are no longer required. The company also said it received FDA advice on the LIBERTY Phase 3 trial comparing VYD2311 with mRNA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLxmvzL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","BK4588","LU2210149790.SGD","BK4112","BK4539","NDAQ","BK4139","SG9999014005.SGD","IVVD","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014021.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617411415","title":"Invivyd Names Michael Mina Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2617411415","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617411415?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712195,"startTime":"0","endTime":"0","summary":"Invivyd Inc. appointed Michael Mina, M.D., Ph.D. as its Chief Medical Officer. Mina previously served as an assistant professor at the Harvard T.H. Chan School of Public Health, Harvard Medical School, and Brigham and Women’s Hospital, and has held chief science or chief medical officer roles at diagnostics and digital health companies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL22FHgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","LU0314104364.USD","LU2095319765.USD","BK4585","BK4139","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4539","BK4112","SG9999014039.USD","IVVD","SG9999014021.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617541180","title":"Invivyd FY Net Income USD -52.489 Million VS. Ibes Estimate USD -57.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541180?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX537BEB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IVVD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617411295","title":"Press Release: Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2617411295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617411295?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712180,"startTime":"0","endTime":"0","summary":"-- Achieved Q4 2025 PEMGARDA  net product revenue of $17.2. million, representing 25% growth year-over-year and 31% growth. -- 2025 year-end cash and cash equivalents of $226.7 million after raising. over $200 million from financing transactions in 2H 2025. -- Announced initiation of DECLARATION Phase 3 pivotal clinical trial of. vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data. expected mid-2026; Fast Track designation for VYD2311 granted by FDA in. prespecified review of unblinded VYD2311 safety data resulted in IDMC. recommendation to allow enrollment of pregnant and breastfeeding women in. \"With potential commercialization of VYD2311 on the horizon, we are encouraged by continued commercial execution and appeal for monoclonal antibody prophylaxis demonstrated by revenue of PEMGARDA  more than doubling year over year, while operating expenses were reduced by nearly half,\" noted Bill Duke, Chief Financial Officer of Invivyd. \"While we are pleased with Invivyd","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","R","BK4232","BK4022","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617987541","title":"Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2617987541","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617987541?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712060,"startTime":"0","endTime":"0","summary":"-- Former assistant professor of epidemiology, immunology, and infectious. disease at the Harvard T.H. Chan School of Public Health and pathology at. Harvard Medical School and Brigham and Women's Hospital, Dr. Mina. -- Dr. Mina's research at Harvard focused on antibodies, vaccines, and. other diseases, and will be a significant asset to Invivyd and the. Dr. Mina is a former assistant professor at the Harvard T.H. Chan School of Public Health, Harvard Medical School and Brigham and Women's Hospital, and he has served as chief science or chief medical officer at several diagnostics and digital health companies. Dr. Mina rose to prominence during the COVID pandemic advising the U.S. federal and international governments on testing policies and advocating that the U.S. shift its public health goal from attempting to diagnose every COVID case, to identifying who was contagious at the moment in order to reduce transmission and accelerate reopening society. Dr. Mina helped lead the U.S. gove","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616323627","title":"Invivyd Inc  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323627","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323627?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:39","pubTimestamp":1772545146,"startTime":"0","endTime":"0","summary":"Invivyd Inc  expected to post a loss of8cents a share - Earnings Preview Invivyd Inc IVVD.OQ IVVD.O is expected to  show a rise in quarterly revenue when it reports  results on March 5 for the period ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR1PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616366693","title":"Invivyd Grants 192,000 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366693","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366693?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:01","pubTimestamp":1772485270,"startTime":"0","endTime":"0","summary":"Invivyd said it granted stock options to four newly hired non-executive employees covering a total of 192,000 shares. The options have an exercise price of $1.69 per share, vest over four years with 25% vesting after one year and the remainder vesting monthly thereafter, and have a 10-year term.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3jVNCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4585","NDAQ","LU2095319765.USD","BK4112","SG9999014021.USD","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","BK4588","SG9999014039.USD","SG9999014013.SGD","IVVD","LU2210149790.SGD","LU0314104364.USD","IE00B64PRP62.GBP","BK4539","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614043338","title":"Invivyd Price Target Maintained With a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043338","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614043338?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:37","pubTimestamp":1772105820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVVD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 06:37 ET (11:37 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":82,"code":"91000000","status":"200"}]}}